Kolumne, ORE

Original-Research: MAX Automation SE - from NuWays AG Classification of NuWays AG to MAX Automation SE Company Name: MAX Automation SE ISIN: DE000A2DA588 Reason for the research: Update Recommendation: Kaufen from: 29.04.2024 Target price: EUR 8.20 Target price on sight of: 12 Monaten Last rating change: Analyst: Konstantin Völk MAX achieved attractive sales price for MA micro; chg.

29.04.2024 - 09:01:39

Original-Research: MAX Automation SE (von NuWays AG): Kaufen


Original-Research: MAX Automation SE - from NuWays AG

Classification of NuWays AG to MAX Automation SE

Company Name: MAX Automation SE
ISIN: DE000A2DA588

Reason for the research: Update
Recommendation: Kaufen
from: 29.04.2024
Target price: EUR 8.20
Target price on sight of: 12 Monaten
Last rating change: 
Analyst: Konstantin Völk

MAX achieved attractive sales price for MA micro; chg. est.
 
Topic: MAX Automation has come to an agreement on the divestment of its
subsidiary MA micro with an attractive purchase price, sale of MA micro
anticipated in the second half of FY24e.
 
MAX Automation announced the sale of MA micro (intention was announced in
September 2023), which was already part of discontinued operations at the
end of FY23 to the Japanese conglomerate, Hitachi Ltd. The purchase price
of EUR 71.5 - 76.5m is still subject to the FY24e performance of MA micro.
   
After the acquisition is completed, MA micro will join JR Automation
Technologies, a Hitachi group company, and market leader in providing
advanced automation solutions and digital technologies in the robotics
systems integration business. The transaction is subject to various
customary conditions, in particular the granting of merger control
approvals and is expected to be closed in the second half of FY24e. MAX
intends to use the proceeds from the sale primarily to reduce financial
liabilities by partially repaying the syndicated loan (end of FY23: EUR
120.8m).
 
The sale has no influence on our financial estimates of FY24e as MA micro
was already part of discontinued operations. However, as the proceeds will
be used to partially repay the syndicated loan (eNuW: 10% interest rate),
annual interest expenses should decline by EUR 7.4m, potentially boosting EPS
by 40% (eNuW), not reflected in our estimates until the transaction closed.
 
Taking into account the weak operating performance of MA micro during the
last year (-28% revenue yoy, -17% EBITDA yoy) and a likely further
deterioration in FY24 due to the subdued order momentum (eNuW), the
purchase price looks attractive in our view (eNuW FY24e: Sales EUR 40m, EUR
6.6m EBITDA). The implied sales multiple of 11x EV/EBITDA is 30% above the
group's  current valuation of 8.5x, which underpins the undervaluation of
the stock. Mind you, the crown jewel bdtronic and Vecoplan have bright
business prospects and should be worth considerably more than 8.0x
EV/EBITDA.
 
We reiterate BUY with an unchanged EUR 8.20 PT based on DCF.

You can download the research here:
http://www.more-ir.de/d/29553.pdf
For additional information visit our website
www.nuways-ag.com/research.

Contact for questions
NuWays AG  - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

-------------------transmitted by EQS Group AG.-------------------


The issuer is solely responsible for the content of this research.
The result of this research does not constitute investment advice
or an invitation to conclude certain stock exchange transactions.

@ dpa.de

Weitere Meldungen

Original-Research: ParTec AG (von First Berlin Equity Research GmbH): Buy Original-Research: ParTec AG - from First Berlin Equity Research GmbH 22.11.2024 / 11:20 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. (Boerse, 22.11.2024 - 11:21) weiterlesen...

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research... Original-Research: Cardiol Therapeutics Inc - from First Berlin Equity Research GmbH 22.11.2024 / 11:05 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. (Boerse, 22.11.2024 - 11:06) weiterlesen...

Original-Research: ad pepper media International N.V. (von First Berlin Equit... Original-Research: ad pepper media International N.V. - from First Berlin Equity Research GmbH 22.11.2024 / 10:45 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. (Boerse, 22.11.2024 - 10:46) weiterlesen...

Original-Research: NFON AG (von NuWays AG): Buy Original-Research: NFON AG - from NuWays AG 22.11.2024 / 09:05 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. (Boerse, 22.11.2024 - 09:06) weiterlesen...

Original-Research: Nabaltec AG (von NuWays AG): Buy Original-Research: Nabaltec AG - from NuWays AG 22.11.2024 / 09:01 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. (Boerse, 22.11.2024 - 09:02) weiterlesen...

Original-Research: mVISE AG (von NuWays AG): Buy Original-Research: mVISE AG - from NuWays AG 22.11.2024 / 09:01 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. (Boerse, 22.11.2024 - 09:01) weiterlesen...